EPAM Reports Results for Second Quarter 2026

EPAM reported Q2 revenue of $1.415B (+4.5% YoY) and GAAP diluted EPS of $1.97 (+26.3% YoY), alongside non-GAAP diluted EPS of $3.38 (+22.0%). Profitability improved, with GAAP operating income rising to 10.8% of revenue from 9.3% a year earlier (non-GAAP operating income to 16.4% from 15.0%). The company raised/updated full-year outlook to GAAP diluted EPS of $8.22–$8.38 (non-GAAP $13.08–$13.24) and continues capital returns, repurchasing $85M in Q2 and $409M since the start of the year.

Analysis

This print is less about a cyclical reacceleration and more about operating leverage: the market will pay up if EPAM can prove that AI delivery is improving mix and utilization faster than it is diluting billable hours. That favors EPAM over legacy IT services names with weaker engineering depth, and it should also help the entire digital-engineering bucket (CTSH, INFY, WIT) trade on relative quality rather than absolute growth. The key second-order effect is pricing power: if clients are willing to pay for forward-deployed engineering talent instead of generic staff augmentation, smaller shops will feel rate pressure first.

The main near-term risk is that buybacks are carrying a bigger share of EPS than the operating cash profile would suggest. If working capital stays loose or collections normalize, the market may stop giving full credit to earnings beats that are partially financial-engineering driven. Over the next 1-3 months, the stock should be driven by whether analysts raise organic growth and margin estimates; over 6-18 months, the real upside case depends on AI work moving from pilot budgets into repeatable production revenue.

Consensus may be overestimating how immediately monetizable the AI narrative is for services. AI often compresses labor content before it expands demand, so the best outcome for EPAM may be stronger margins with only modest growth, which is good for the stock but not enough to justify a rerating if the multiple already discounts a growth inflection. Falsifier: organic growth slipping back below 2% and/or margin failing to hold near current levels despite continued repurchases.

Key Decisions for Investors

• Long EPAM on post-earnings weakness, 1-3 month horizon; thesis is margin leverage and estimate revisions, not a top-line breakout. Risk/reward is attractive if the market keeps rewarding AI-enabled execution and buyback support.
• Pair trade: long EPAM / short CTSH for 1-3 months. EPAM has more direct exposure to high-value engineering work; CTSH is more exposed to broad discretionary IT spend and should lag if buyers keep prioritizing AI-native delivery over traditional services.
• If EPAM trades to a premium multiple without a clear improvement in cash conversion, fade strength by trimming or selling covered calls. The risk is that EPS is being flattered faster than free cash flow is recovering.
• Set a watch item for the next quarter: organic constant-currency growth below 2% or operating margin compression would invalidate the AI-share-gain thesis and shift the trade from long to neutral.